Cargando…

THE MULBSTA SCORE: PREDICTING RISK OF MORTALITY AND DISEASE SEVERITY IN PATIENTS WITH COVID-19 PNEUMONIA

Detalles Bibliográficos
Autores principales:	Tusha, Jurgena, Khanam, Verisha, Tegeltija, Vesna, Kumar, Sarwan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2020
Materias:	Chest Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548654/ http://dx.doi.org/10.1016/j.chest.2020.08.299

Ejemplares similares

CLINICAL CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH COVID-19 IN A COMMUNITY HOSPITAL IN MICHIGAN
por: Tusha, Jurgena, et al.
Publicado: (2020)

SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE IN PATIENTS INFECTED WITH SARS COV-2
por: Khanam, Verisha, et al.
Publicado: (2020)

THE SIGNIFICANCE OF ORAL ASCORBIC ACID IN PATIENTS WITH COVID-19
por: Patel, Manishkumar, et al.
Publicado: (2020)

SUDDEN CARDIAC DEATH AND THE PECULIAR COVID-19 CASE
por: Abkouh, Danyal Taheri, et al.
Publicado: (2020)

BIOMARKER OF COVID PNEUMONIA VS CONGESTIVE HEART FAILURE: A KEY TO DISEASE DIAGNOSIS
por: Al-janabi, Laith, et al.
Publicado: (2020)

Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
por: Guo, Lingxi, et al.
Publicado: (2019)

Erratum: Clinical Features Predicting Mortality Risk in Patients With Viral Pneumonia: The MuLBSTA Score
Publicado: (2020)

THE ROLE OF ASCORBIC ACID IN REDUCING MORTALITY IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: KHOKHER, WALEED, et al.
Publicado: (2021)

SEVERE ADENOVIRUS PNEUMONIA IN RITUXIMAB INFUSIONS
por: BJORK, SARAH, et al.
Publicado: (2021)

UNEXPECTED OPPORTUNISTIC INFECTION IN PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: NIEVES, HÉCTOR, et al.
Publicado: (2021)

CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA
por: Hong, Gloria, et al.
Publicado: (2020)

SEVERE COVID-19 PNEUMONIA IN A FULLY VACCINATED IMMUNOCOMPROMISED PATIENT
por: SUBRAMANIAN, LAKSHMI, et al.
Publicado: (2021)

COMPARISON OF SIRS CRITERIA, QSOFA SCORE, AND A COMBINATION OF BOTH FOR THE DIAGNOSIS OF SEPSIS AND PREDICTION OF MORTALITY IN HOSPITALIZED ADULT PATIENTS WITH COVID-19
por: XUE, JUNFENG, et al.
Publicado: (2021)

BASELINE CHARACTERISTICS AND PREDICTORS FOR ALL-CAUSE MORTALITY IN PATIENTS HOSPITALIZED WITH COVID-19 PNEUMONIA
por: CHAROENPONG, PRANGTHIP, et al.
Publicado: (2021)

MuLBSTA score in COVID-19 pneumonia and prediction of 14-day mortality risk: A study in an Indian cohort
por: Preetam, Mukul, et al.
Publicado: (2021)

PREDICTOR VARIABLES FOR MORTALITY IN THE 48 HOURS PRIOR TO ENDOTRACHEAL INTUBATION IN PATIENTS WITH COVID-19 PNEUMONIA
por: SHER, NEHAN, et al.
Publicado: (2021)

PREVOTELLA BIVIA BACTEREMIA POST TOCILIZUMAB IN A PATIENT WITH SEVERE COVID-19 PNEUMONIA
por: AIYANYOR, ALFRED, et al.
Publicado: (2021)

IMPACT OF ADMISSION TROPONIN AND TROPONIN RISE DURING HOSPITALIZATION ON MORTALITY IN COVID-19 PNEUMONIA WITH ACUTE RESPIRATORY FAILURE
por: GUPTA, MANASVI, et al.
Publicado: (2021)

E. COLI PNEUMONIA WITH PNEUMATOCELE, EMPYEMA NECESSITANS, AND BRONCHOPLEURAL FISTULA IN A PATIENT WITH SEVERE COVID-19
por: Kahn, Michael, et al.
Publicado: (2020)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 ISOLATION FROM PLEURAL FLUID WITH COVID-19 PNEUMONIA AND SUPERIMPOSED EMPYEMA
por: Leys, Lorenzo, et al.
Publicado: (2020)

TIME TO EXPAND THE USE OF CASIRIVIMAB/IMDEVIMAB MONOCLONAL ANTIBODY THERAPY? A CASE OF COMPASSIONATE USE IN SEVERE COVID-19 PNEUMONIA
por: AHMED, MUBASHIR AYAZ, et al.
Publicado: (2022)

MARKEDLY ELEVATED TROPONIN WITH COVID-19 PNEUMONIA WITHOUT ACUTE CORONARY SYNDROME
por: KUMAR, DILEEP, et al.
Publicado: (2021)

CAN OUTCOMES IN PATIENTS WITH COVID-19 PNEUMONIA AND ACUTE RESPIRATORY BE PREDICTED WITH ADMISSION SERUM LACTIC ACID LEVELS?
por: NGUYEN, SUONG, et al.
Publicado: (2021)

LETHAL FUNGEMIA IN COVID-19 PNEUMONIA
por: PLEMMONS, ANNA, et al.
Publicado: (2021)

POST-COVID-19 EOSINOPHILIC PNEUMONIA
por: SHAH, DHIRAJ, et al.
Publicado: (2022)

D-DIMER AS A SURROGATE MARKER OF DISEASE SEVERITY IN AFRICAN AMERICAN POPULATION WITH COVID-19 PNEUMONIA: A COMMUNITY HOSPITAL RETROSPECTIVE STUDY
por: OMORE, IBRAHIM, et al.
Publicado: (2021)

Which role for chest x-ray score in predicting the outcome in COVID-19 pneumonia?
por: Maroldi, Roberto, et al.
Publicado: (2020)

IMPACT OF DEMENTIA AS AN EARLY MORTALITY RISK FACTOR AMONG DECEASED PATIENTS WITH COVID-19
por: RUIZ, CARLOS A PEREZ, et al.
Publicado: (2022)

BILATERAL PNEUMOTHORACES IN A PATIENT WITH COVID PNEUMONIA
por: Ul Haq, Irfan, et al.
Publicado: (2020)

A COMPARISON OF THE INCIDENCE OF VENTILATOR-ASSOCIATED PNEUMONIA AMONG PATIENTS WITH COVID-19 AND INFLUENZA PNEUMONIA A AND B
por: GROSSMAN, J., et al.
Publicado: (2022)

Validation of MuLBSTA score to derive modified MuLB score as mortality risk prediction in COVID-19 infection
por: George, Richie, et al.
Publicado: (2022)

PREDICTING COVID-19 SEVERITY USING A SIMPLE PARAMETERS IN RESOURCE-LIMITED SETTINGS
por: NIMITVILAI, S., et al.
Publicado: (2022)

JAK ANTAGONISTS AND IL-6 INHIBITORS FOR MANAGEMENT OF SARS-COV-2 INFECTION: A SYSTEMIC REVIEW AND NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
por: KHANAM, RUKHSAAR, et al.
Publicado: (2022)

UPFRONT COMMUNITY-ACQUIRED PNEUMONIA ANTIMICROBIAL THERAPY IS ASSOCIATED WITH REDUCED RATES OF VENTILATOR-ASSOCIATED PNEUMONIA IN PATIENTS WITH COVID-19
por: WAKEFIELD, CONNOR, et al.
Publicado: (2022)

CLINICAL OUTCOMES OF PATIENTS WITH ASTHMA WITH COVID-19 PNEUMONIA
por: Brinton, Taylor, et al.
Publicado: (2020)

RESTRICTIVE LUNG DEFECT IN POST-COVID-19 PNEUMONIA
por: TAWEESEDT, PAHNWAT, et al.
Publicado: (2021)

LEAKY LUNGS: A COMPLICATION OF COVID-19 PNEUMONIA
por: ADHIKARI, PRAKASH, et al.
Publicado: (2021)

NOT EVERYTHING IS COVID: PERSISTENT FEVER AND MALAISE MIMICKING COVID-19 PNEUMONIA
por: ATUAKA, CHRISTIANA, et al.
Publicado: (2021)

Comparison of semiquantitative chest CT scoring systems to estimate severity in coronavirus disease 2019 (COVID-19) pneumonia
por: Inoue, Akitoshi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_albn3n04ichgha55fsv55bkhru